- $111.20m
- $122.80m
- $148.09m
- 99
- 89
- 62
- 97
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 133 | 116 | 117 | 143 | 148 |
Cost of Revenue | |||||
Gross Profit | 48.8 | 41.4 | 43.7 | 48.2 | 53.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 131 | 114 | 109 | 137 | 139 |
Operating Profit | 2.43 | 2.43 | 8.72 | 5.44 | 8.8 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.37 | 2.18 | 7.03 | 3.41 | 6.07 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.76 | 1.28 | 6.43 | 2.66 | 4.69 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1.76 | 1.28 | 6.43 | 2.66 | 4.69 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.76 | 1.28 | 6.43 | 2.66 | 4.69 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.243 | 0.179 | 0.406 | 0.361 | 0.964 |
Dividends per Share |